IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-23334-2.html
   My bibliography  Save this article

Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes

Author

Listed:
  • Kerstin Renner

    (University Hospital Regensburg)

  • Tobias Schwittay

    (University Hospital Regensburg)

  • Sophia Chaabane

    (University Hospital Regensburg)

  • Johanna Gottschling

    (University Hospital Regensburg)

  • Christine Müller

    (University Hospital Regensburg)

  • Charlotte Tiefenböck

    (University Hospital Regensburg)

  • Jan-Niklas Salewski

    (University Hospital Regensburg)

  • Frederike Winter

    (University Hospital Regensburg
    Regensburg Center for Interventional Immunology)

  • Simone Buchtler

    (University Hospital Regensburg)

  • Saidou Balam

    (University Hospital Regensburg)

  • Maximilian V. Malfertheiner

    (University Hospital Regensburg)

  • Matthias Lubnow

    (University Hospital Regensburg)

  • Dirk Lunz

    (University Hospital Regensburg)

  • Bernhard Graf

    (University Hospital Regensburg)

  • Florian Hitzenbichler

    (University Hospital Regensburg)

  • Frank Hanses

    (University Hospital Regensburg)

  • Hendrik Poeck

    (University Hospital Regensburg)

  • Marina Kreutz

    (University Hospital Regensburg)

  • Evelyn Orsó

    (University Hospital Regensburg)

  • Ralph Burkhardt

    (University Hospital Regensburg)

  • Tanja Niedermair

    (University of Regensburg
    University and University Hospital)

  • Christoph Brochhausen

    (University of Regensburg
    University and University Hospital)

  • André Gessner

    (University Hospital Regensburg)

  • Bernd Salzberger

    (University Hospital Regensburg)

  • Matthias Mack

    (University Hospital Regensburg
    Regensburg Center for Interventional Immunology)

Abstract

Coronavirus disease 2019 (COVID-19) can lead to pneumonia and hyperinflammation. Here we show a sensitive method to measure polyclonal T cell activation by downstream effects on responder cells like basophils, plasmacytoid dendritic cells, monocytes and neutrophils in whole blood. We report a clear T cell hyporeactivity in hospitalized COVID-19 patients that is pronounced in ventilated patients, associated with prolonged virus persistence and reversible with clinical recovery. COVID-19-induced T cell hyporeactivity is T cell extrinsic and caused by plasma components, independent of occasional immunosuppressive medication of the patients. Monocytes respond stronger in males than females and IL-2 partially restores T cell activation. Downstream markers of T cell hyporeactivity are also visible in fresh blood samples of ventilated patients. Based on our data we developed a score to predict fatal outcomes and identify patients that may benefit from strategies to overcome T cell hyporeactivity.

Suggested Citation

  • Kerstin Renner & Tobias Schwittay & Sophia Chaabane & Johanna Gottschling & Christine Müller & Charlotte Tiefenböck & Jan-Niklas Salewski & Frederike Winter & Simone Buchtler & Saidou Balam & Maximili, 2021. "Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
  • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23334-2
    DOI: 10.1038/s41467-021-23334-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-23334-2
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-021-23334-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23334-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.